Skip to main content

Table 1 Clinical details of the studied patients

From: Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection

 

Normal control

HBV carrier

AHB

CHB

ACHBLF

Number

10

12

10

18

18

Age (years)

30 (24 ~ 42)

25(22 ~ 34)

40 (32 ~ 45)

37 (21 ~ 68)

45 (30 ~ 65)

Gender(male/female)

7/3

8/4

8/2

14/4

14/4

HBeAg positive

NA

12

2

11

7

HBV DNA

     

(Log 10 IU/mL)

NA

8.3(7.24‒9.72)

3.00(2‒3.12)

5.15(2.12‒6.73)

4.53(2.94‒7.14)

ALT(IU/L)

NA

23.5(13‒42)

915(67‒1226)

126(65‒988)

125(21‒1002)

TBil (μmol/L)

NA

10.5(5‒16)

111(60‒210)

18.8(8.9‒151)

457.2(170‒599)

Encephalopathy grade III/IV(%)

NA

0

0

0

35.29

Ascites(%)

NA

0

0

0

82.35

Mortality (%)

NA

0

0

0

23.53

  1. Data are expressed as median (range) or number. NA, not applicable; AHB, Acute hepatitis B; CHB, chronic hepatitis B; ACHBLF, Acute-on-chronic HBV-related liver failure; ALT, Alanine aminotransferase; TBil, total bilirubin; Normal values:ALT,0–60 U/l; total bilirubin, 2–17 μmol/L.